Current Insights of BRAF Inhibitors in Cancer-Reference-Cited by-同舟云学术

Current Insights of BRAF Inhibitors in Cancer

Published:2018-02-20 Issue:14 Volume:61 Page:5775-5793
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Agianian Bogos¹,Gavathiotis Evripidis¹^ORCID

Affiliation:

1. Department of Biochemistry and Department of Medicine, Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461, United States

Funder

National Institutes of Health

Melanoma Research Alliance

Irma T. Hirschl Trust

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01306

Reference128 articles.

1. The RAF proteins take centre stage

2. New perspectives for targeting RAF kinase in human cancer

3. Regulation of RAF protein kinases in ERK signalling

4. Targeting RAS–ERK signalling in cancer: promises and challenges

5. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. Cell-specific models reveal conformation-specific RAF inhibitor combinations that synergistically inhibit ERK signaling in pancreatic cancer cells;Cell Reports;2024-09

3. Adenine, a key player in biology and medicinal chemistry;Comptes Rendus. Chimie;2024-07-11

4. Structure-Based De Novo Design for the Discovery of Miniprotein Inhibitors Targeting Oncogenic Mutant BRAF;International Journal of Molecular Sciences;2024-05-19

5. Insights into the structure-activity relationship of pyrimidine-sulfonamide analogues for targeting BRAF V600E protein;Biophysical Chemistry;2024-04